Authors:
Kanter-Lewensohn, L
Girnita, L
Girnita, A
Dricu, A
Olsson, G
Leech, L
Nilsson, G
Hilding, A
Wejde, J
Brismar, K
Larsson, O
Citation: L. Kanter-lewensohn et al., Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway, MOL C ENDOC, 165(1-2), 2000, pp. 131-137
Authors:
Fernholm, R
Bramnert, M
Hagg, E
Hilding, A
Baylink, DJ
Mohan, S
Thoren, M
Citation: R. Fernholm et al., Growth hormone replacement therapy improves body composition and increasesbone metabolism in elderly patients with pituitary disease, J CLIN END, 85(11), 2000, pp. 4104-4112
Authors:
Saaf, M
Hilding, A
Thoren, M
Troell, S
Hall, K
Citation: M. Saaf et al., Growth hormone treatment of osteoporotic postmenopausal women - a one-yearplacebo-controlled study, EUR J ENDOC, 140(5), 1999, pp. 390-399
Authors:
Hilding, A
Hall, K
Wivall-Helleryd, IL
Saaf, M
Mellin, AL
Thoren, M
Citation: A. Hilding et al., Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects, J CLIN END, 84(6), 1999, pp. 2013-2019
Authors:
Olivecrona, H
Hilding, A
Ekstrom, C
Barle, H
Nyberg, B
Moller, C
Delhanty, PJ
Baxter, RC
Angelin, B
Ekstrom, TJ
Tally, M
Citation: H. Olivecrona et al., Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: Serum levels and hepatic messenger ribonucleic acid responses in humans, J CLIN END, 84(2), 1999, pp. 553-560